Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Forecast 2026–2035 Showcasing Industry Insights and Data Trends
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market During The Forecast Period 2026–2030?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market size has experienced rapid expansion in recent years. It is projected to increase from $5.14 billion in 2025 to $5.79 billion in 2026, maintaining a compound annual growth rate (CAGR) of 12.6%. The market’s historical growth can be ascribed to factors such as the limited availability of mRNA synthesis platforms, early-stage research in mRNA therapeutics, reliance on small-scale laboratory production, nascent regulatory frameworks, and the high cost of purification and formulation services.
The messenger ribonucleic acid (mrna) synthesis and manufacturing market size is expected to undergo substantial expansion over the next few years. It is anticipated to reach $9.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.3%. The growth observed in the forecast period can be attributed to advancements in automated mRNA synthesis technologies, the expansion of commercial-scale mRNA manufacturing facilities, increasing investment in vaccine and therapeutic pipelines, a rising demand for self-amplifying mRNA and novel formulations, and an increase in preclinical and clinical research collaborations. Key trends for the forecast period include the increasing adoption of gmp-compliant mrna synthesis, a growing demand for large-scale mrna production, the expansion of mrna therapeutics and vaccine pipelines, a greater focus on purification, capping, and tailing services, and the increasing integration of mrna-lnp formulations and stability testing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25832&type=smp
Which Economic Or Industry Drivers Are Impacting The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
The rising occurrence of infectious diseases is anticipated to boost the expansion of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in the future. These diseases are health conditions resulting from disease-causing microorganisms like bacteria, viruses, fungi, or parasites, encompassing illnesses such as malaria, which can be transmitted both directly and indirectly. The surge in infectious disease prevalence stems from swift urbanization, creating denser populations and increased human interaction, thereby accelerating infection transmission. mRNA synthesis and manufacturing contribute to fighting infectious diseases by facilitating the quick creation and large-scale manufacturing of specific vaccines and treatments designed to elicit a particular immune reaction. As an illustration, the World Health Organization, an international public health organization based in Switzerland, reported in October 2024 that about 8.2 million individuals received new tuberculosis diagnoses in 2023, an increase from roughly 7.5 million in 2022, identifying tuberculosis as the deadliest infectious disease. Consequently, the growing incidence of infectious diseases is fueling the development of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market.
What Market Segments Are Evaluated Within The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –
1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas
4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services
What Industry Trends Are Redefining The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
Companies actively engaged in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market are prioritizing the creation of advanced products, such as co-transcriptional capping platforms, to expedite preclinical investigations and ease regulatory burdens. A co-transcriptional capping platform refers to a proprietary technique designed for the efficient attachment of a protective cap to messenger ribonucleic acid (mRNA) molecules during their synthesis, thereby improving mRNA stability, enhancing translation efficiency, and enabling control over immunogenicity. As an illustration, in May 2025, GenScript, a US-based provider of life sciences research tools, introduced its good manufacturing practice (GMP)-like messenger ribonucleic acid (mRNA) manufacturing service. This particular service is a scalable and regulatory-conscious manufacturing solution developed to generate high-purity, functional mRNA suitable for investigational new drug (IND)-enabling preclinical research, including assessments such as toxicology, biodistribution, and pharmacokinetics or pharmacodynamics (PK or PD). It operates within cleanroom-compliant, International Organization for Standardization (ISO) 7-classified settings and integrates patented co-transcriptional capping technology. This offering ensures the delivery of personalized mRNA in a timeframe as short as seven weeks. Such an advancement effectively closes the significant development divide between research-grade and full GMP manufacturing, empowering nascent biotechnology and pharmaceutical firms to carry out regulatory-compliant studies without incurring the substantial expenses and prolonged timelines associated with conventional GMP production.
Who Are The Top Market Participants Influencing The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC
Read the full messenger ribonucleic acid (mrna) synthesis and manufacturing market report here:
What Are The Top-Performing Regions Within The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25832&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
